首页> 美国卫生研究院文献>Pharmaceutics >Characterization Stability and In Vivo Efficacy Studies of Recombinant Human CNTF and Its Permeation into the Neural Retina in Ex Vivo Organotypic Retinal Explant Culture Models
【2h】

Characterization Stability and In Vivo Efficacy Studies of Recombinant Human CNTF and Its Permeation into the Neural Retina in Ex Vivo Organotypic Retinal Explant Culture Models

机译:重组人CNTF的表征稳定性和体内疗效研究及其渗透到前体内有机型视网膜培养基中的神经视网膜中的渗透

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ciliary neurotrophic factor (CNTF) is one of the most studied neuroprotective agents with acknowledged potential in treating diseases of the posterior eye segment. Although its efficacy and mechanisms of action in the retina have been studied extensively, it is still not comprehensively understood which retinal cells mediate the therapeutic effects of CNTF. As with therapeutic proteins in general, it is poorly elucidated whether exogenous CNTF administered into the vitreous can enter and distribute into the retina and hence reach potentially responsive target cells. Here, we have characterized our purified recombinant human CNTF (rhCNTF), studied the protein’s in vitro bioactivity in a cell-based assay, and evaluated the thermodynamic and oligomeric status of the protein during storage. Biological activity of rhCNTF was further evaluated in vivo in an animal model of retinal degeneration. The retinal penetration and distribution of rhCNTF after 24 h was studied utilizing two ex vivo retina models. Based on our characterization findings, our rhCNTF is correctly folded and biologically active. Moreover, based on initial screening and subsequent follow-up, we identified two buffers in which rhCNTF retains its stability during storage. Whereas rhCNTF did not show photoreceptor preservative effect or improve the function of photoreceptors in vivo, this could possibly be due to the used disease model or the short duration of action with a single intravitreal injection of rhCNTF. On the other hand, the lack of in vivo efficacy was shown to not be due to distribution limitations; permeation into the retina was observed in both retinal explant models as in 24 h rhCNTF penetrated the inner limiting membrane, and being mostly observed in the ganglion cell layer, distributed to different layers of the neural retina. As rhCNTF can reach deeper retinal layers, in general, having direct effects on resident CNTF-responsive target cells is plausible.
机译:睫状神经营养因子(CNTF)是具有在治疗后眼部疾病的疾病中具有最多研究的神经保护剂之一。尽管在视网膜中的功效和作用机制已经进行了广泛研究,但仍然没有全面理解哪种视网膜细胞介导CNTF的治疗效果。与治疗性蛋白质相一般,施加到玻璃体中的外源CNTF是较差的才能进入和分布到视网膜中,因此达到潜在的响应靶细胞。在这里,我们表征了我们的纯化的重组人CNTF(RHCNTF),在基于细胞的测定中研究了蛋白质的体外生物活性,并在储存期间评估了蛋白质的热力学和低聚状态。在视网膜变性的动物模型中进一步评估了rhCNTF的生物活性。使用两个离体视网膜模型研究了24小时后RHCNTF的视网膜渗透和分布。根据我们的表征调查结果,我们的RHCNTF是正确折叠和生物活跃的。此外,基于初始筛选和随后的随访,我们确定了两种缓冲器,其中RHCNTF在储存期间保留其稳定性。而rhcntf没有显示出光感受器防腐效果或改善体内光感受器的功能,这可能是由于使用过的疾病模型或短暂的动作持续时间,单一的术术反射rhcntf。另一方面,缺乏体内疗效被认为不是由于分配限制;在两种视网膜外蛋白模型中观察到视网膜渗透到视网膜模型中,如24小时rhCNTF穿过内部限制膜,并且在神经节细胞层中大多观察到分布到神经视网膜的不同层。由于RHCNTF可以达到更深的视网膜层,通常,对常规的CNTF响应靶细胞具有直接影响是合理的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号